MedTrace Logo

Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy

NCT00873054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2014-02-03

No results posted yet for this study

Summary

The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which treatment is safe and prevent less stone recurrence.

Conditions

  • Kidney Stones

Sponsors & Collaborators

  • CAMC Health System

    lead OTHER

Principal Investigators

  • Julio G. Davalos, MD · CAMC Medical Staff - with admitting privileges

  • Frederick Martinez, M.D. · CAMC Medical Staff - with admitting privileges

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-10-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00873054 on ClinicalTrials.gov